库尔库米诺酸:合成,稳定性,以及新的神经保护和声敏活动
Dorota Olender1, Małgorzata Józkowiak2, Hanna Piotrowska-Kempisty2
1Department of Organic Chemistry, Pharmaceutical Faculty, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2023
概括
新的curcuminoid chalcone-NSAID杂交物被合成并评估在声动疗中神经保护. 这些化合物显示出口服药物传递的潜力,尽管在某些环境中不稳定.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 库尔库米诺类石具有多样化的生物活动.
- 非类固醇抗炎药物 (NSAIDs) 广泛用于治疗疼痛和炎症.
- 混合分子提供了增强治疗效果的潜力.
研究的目的:
- 设计和合成新型的氨酸和NSAID混合衍生物.
- 评估合成的化合物用于声动力学治疗,抗炎,抗氧化和抗胆性质.
- 评估潜在药物配方有前途的混合化合物的稳定性.
主要方法:
- 通过克莱森-施密特和斯泰格利希化反应进行合成.
- 使用FT-IR,MS和NMR光谱学进行结构确认.
- 使用RP-HPLC评估声动力学,抗炎,抗氧化,抗胆固醇活性和稳定性.
主要成果:
- 成功合成和表征了新型的胺酸和NSAID Ester型混合体.
- 库尔库米诺伊德 (curcuminoid) 石墨衍生物作为声敏剂显示出有前途的神经保护作用.
- 混合化合物在酸性,性和中性环境中表现出不稳定性,但在pH 1.2和6.8.8时表现出稳定性.
结论:
- 合成的库尔库米诺伊德 chalcone-NSAID 杂交物具有声动疗和神经保护的潜力.
- 特定的类混合化合物具有适合口服配方的稳定性.
- 需要进一步的研究来优化这些化合物用于治疗应用.
相关概念视频
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Chirality in Nature
13.5K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
13.5K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
709
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
709
Prochirality
3.8K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
3.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
600
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
600


